Figure 6From: Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer’s disease pathology in TgSwDI and 3xTg mouse models Quantitation of amyloid burden in the amygdala of TgSwDI mice. Representative brain sections of both (A) vehicle control and (B) pBri-treated Tg mice immunostained with anti-Aβ antibodies 4G8 and 6E10 from the amygdala. (C) Bar graph of amyloid burden calculated using stereology for the amygdala of vehicle control and pBri-vaccinated TgSwDI mice. On average there was a 72% reduction in the areas occupied by 4G8/6E10 immunoreactivity accounting for precipitated amyloid (*** P < 0.0004 by an unpaired two-tailed t-test). Tg, transgenic.Back to article page